JF
VOR icon

Jump Financial’s Vor Biopharma VOR Stock Holding History

Jump Financial’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.09M Buy
+173,028
New +$2.44M 0.04% 489
2024
Q3 		– Sell
-566
Closed -$11.3K – 2159
2024
Q2 		$11.3K Buy
+566
New +$18.3K ﹤0.01% 1726
2023
Q3 		– Sell
-930
Closed -$57.5K – 2285
2023
Q2 		$57.5K Buy
930
+414
+80% +$37.8K ﹤0.01% 1719
2023
Q1 		$55.6K Buy
+516
New +$57.2K ﹤0.01% 1492

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jump Financial's VOR Position: Q1 2026 in Review

Jump Financial opened a new position in Vor Biopharma (VOR) in Q1 2026: 173,028 shares worth $3.09M. The stake represents 0.04% of the portfolio and ranks #489 among its holdings. This is a return to the name: Jump Financial previously reported a position in VOR as recently as Q2 2024.

Jump Financial first reported a position in VOR in Q1 2023 and has held it in 4 quarters since. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • Jump Financial held 173,028 shares of Vor Biopharma worth $3.09M as of Q1 2026.
  • Vor Biopharma was a new Jump Financial position in Q1 2026.
  • Vor Biopharma made up 0.04% of Jump Financial's portfolio in Q1 2026, its #489 holding.
  • Jump Financial first reported a position in Vor Biopharma in Q1 2023 and has held it in 4 quarters since.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.